Back to Results
First PageMeta Content
Pharmaceutical sciences / Pharmaceuticals policy / Pharmacology / Therapeutics / United States Public Health Service / Medical device / Premarket approval / Regulatory requirement / Criticism of the Food and Drug Administration / Medicine / Food and Drug Administration / Health


prepAreD by Josh makower, mD consulting Professor of medicine, Stanford university; CEO, ExploraMed Development, LLC; Venture Partner, NEA • Aabed meer md-mBa Candidate, Stanford University • lyn Denend research ass
Add to Reading List

Document Date: 2011-02-02 02:52:05

Open Document

File Size: 1,11 MB

Share Result on Facebook

City

Washington / D.C. / /

Company

ExploraMed Development LLC / Lewin Group / /

Continent

America / Europe / /

Country

United States / /

Currency

USD / /

Event

Product Issues / Product Recall / /

Facility

Institute of Medicine / Stanford University / /

IndustryTerm

venture capital / medical technologies / pathway devices / regulatory systems / risk device / higher risk devices / medical technology / /

MedicalCondition

hypertension / obesity / /

Organization

FDA / European Union / U.S. Food and Drug Administration / Institute of Medicine / Stanford university / /

Position

physician advisors / CEO / research associate / Executive / Contents Executive / Professor of medicine / /

Product

Data / /

SportsLeague

Stanford university / /

Technology

200 Medical Technology / medical technology / /

URL

http /

SocialTag